Show
Sort by
-
- Journal Article
- A1
- open access
Beyond ferrostatin-1 : a comprehensive review of ferroptosis inhibitors
-
- Journal Article
- A1
- open access
From PERK to RIPK1 : design, synthesis and evaluation of novel potent and selective necroptosis inhibitors
-
- Journal Article
- A1
- open access
Targeting ferroptosis protects against experimental (multi)organ dysfunction and death
-
- Journal Article
- A1
- open access
In vitro and in situ activity-based labeling of fibroblast activation protein with UAMC1110-derived probes
-
Targeting ferroptosis protects against multiorgan dysfunction and death
(2021) -
Inhibitors targeting RIPK1/RIPK3 : old and new drugs
-
Caspase-3 probes for PET imaging of apoptotic tumor response to anticancer therapy
-
Synthesis and evaluation of novel benzotropolones as Atg4B inhibiting autophagy blockers
-
- Journal Article
- A2
- open access
DPP8/DPP9 inhibition elicits canonical Nlrp1b inflammasome hallmarks in murine macrophages
-
- Journal Article
- A1
- open access
RIPK1-dependent cell death : a novel target of the Aurora kinase inhibitor Tozasertib (VX-680)
-
Discovery of novel, drug-like ferroptosis inhibitors with in vivo efficacy
-
Tozasertib analogues as inhibitors of necroptotic cell death
-
- Journal Article
- A1
- open access
Virtual screening for inhibitors of the human TSLP:TSLPR interaction
-
When PERK inhibitors turn out to be new potent RIPK1 inhibitors : critical issues on the specificity and use of GSK2606414 and GSK2656157
-
ATG4B inhibitors with a benzotropolone core structure block autophagy and augment efficiency of chemotherapy in mice